European Monitoring Centre for Drugs and Drug Addiction. (2014) Pregnancy and opioid use: strategies for treatment, EMCDDA Papers. Luxembourg: Publications Office of the European Union.
Preview | Title | Contact |
---|---|---|
|
PDF (Full report)
- Published Version
527kB |
Illicit opioid consumption during pregnancy brings with it the risk of an increase in obstetric complications for the mother and a range of potential dangers for the child, both before and after birth. The primary goal when treating opioid dependence in pregnant women is to stabilise the patient and psychosocially assisted opioid substitution treatment is the preferred first-line therapy for this group.
Several combinations of substitution medicines and psychosocial approaches are available. This paper reviews methadone, buprenorphine and slow-release oral morphine, used in a range of combinations with cognitive behavioural approaches and contingency management in order to identify the strengths of each medicine and method.
E Concepts in biomedical areas > Pregnancy
G Health and disease > Disorder by cause > Developmental disorder (reproductive effects)
HJ Treatment method > Substance disorder treatment method > Substance replacement method (substitution)
HJ Treatment method > Substance disorder treatment method > Substance replacement method (substitution) > Opioid agonist treatment (methadone maintenance / buprenorphine)
J Health care, prevention, harm reduction and rehabilitation > Treatment and maintenance > Treatment factors
J Health care, prevention, harm reduction and rehabilitation > Health care delivery
T Demographic characteristics > Pregnant woman
VA Geographic area > Europe
Repository Staff Only: item control page